Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy Katarina BerinderThomas NyströmAnna-Lena Hulting OriginalPaper 03 December 2010 Pages: 199 - 207
Detection of genetic hypopituitarism in an adult population of idiopathic pituitary insufficiency patients with growth hormone deficiency Helena Filipsson NyströmAlexandru SaveanuThierry Brue OriginalPaper 05 December 2010 Pages: 208 - 216
Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population Pedro Weslley Rosario OriginalPaper 18 December 2010 Pages: 217 - 221
Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists Muriel BabeyRahel SahliRolf W. Seiler OriginalPaper Open access 18 December 2010 Pages: 222 - 230
Clinical and biochemical characteristics of acromegalic patients with different abnormalities in glucose metabolism Ana Laura Espinosa-de-los-MonterosBaldomero GonzálezMoisés Mercado OriginalPaper 16 December 2010 Pages: 231 - 235
Intrapituitary cytokines in Cushing’s disease: do they play a role? Agostino PaolettaGiorgio ArnaldiGiacomo Tirabassi OriginalPaper 23 December 2010 Pages: 236 - 241
AMP-activated protein kinase regulates normal rat somatotroph cell function and growth of rat pituitary adenomatous cells Giovanni TulipanoMichela GiovanniniDaniela Cocchi OriginalPaper 07 January 2011 Pages: 242 - 252
Conversion of daily pegvisomant to weekly pegvisomant combined with long-acting somatostatin analogs, in controlled acromegaly patients Sebastian J. C. M. M. NeggersWouter W. de HerderA. J. van der Lely OriginalPaper Open access 08 January 2011 Pages: 253 - 258
Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis Vania dos Santos NunesRegina El DibCélia Regina Nogueira OriginalPaper 08 January 2011 Pages: 259 - 265
The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas Lubin QiuDongsheng HeHaijun Wang OriginalPaper 30 January 2011 Pages: 266 - 275
Excess mortality for patients with residual disease following resection of pituitary adenomas Michael E. SughrueEdward F. ChangLewis S. Blevins ReviewPaper 08 April 2011 Pages: 276 - 283
Clinical, quality of life, and economic value of acromegaly disease control A. Ben-ShlomoM. C. SheppardS. Melmed ReviewPaper Open access 20 May 2011 Pages: 284 - 294
Successful treatment of Cushing’s disease caused by ectopic intracavernous microadenoma Mitsuteru KoizumiTakeshi UsuiAkira Shimatsu Case Report 03 December 2008 Pages: 295 - 298